1. 首頁 > 生活雜燴 > 健康養生 > >

大小|吸入療法3000年前就有了？“簡單”到“細緩”的黑科技蛻變丨奇點深度( 四 )

治療科技患者問題哮喘療法支氣管顆粒肺泡大小氣霧氟利昂福莫特羅


[9].Nave R, Mueller H. From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids[J]. International journal of general medicine, 2013, 6: 99.
[10].Hamid Q, Song Y, Kotsimbos T C, et al. Inflammation of small airways in asthma[J]. Journal of Allergy and Clinical Immunology, 1997, 100(1): 44-51.
[11].張瑋, 丁楠, 曹兆流,等. 吸入裝置的演變過程及研究進展[J]. 藥學服務與研究, 21(1):5.
[12].Azouz W, Chetcuti P, Hosker H S R, et al. The inhalation characteristics of patients when they use different dry powder inhalers[J]. Journal of aerosol medicine and pulmonary drug delivery, 2015, 28(1): 35-42.
[13].Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update[J]. Medical Devices (Auckland, NZ), 2015, 8: 131.
[14].中國醫學裝備協會呼吸病學專委會吸入治療與呼吸康復學組, 中國慢性阻塞性肺疾病聯盟. 穩定期慢性氣道疾病吸入裝置規范應用中國專家共識[J]. 中華結核和呼吸雜志, 2019, 42(4):13.
[15].Ganderton D, Lewis D, Davies R, et al. Modulite?: a means of designing the aerosols generated by pressurized metered dose inhalers[J]. Respiratory medicine, 2002, 96: S3-S8.
[16].Usmani O S, Biddiscombe M F, Barnes P J. Regional lung deposition and bronchodilator response as a function of β2-agonist particle size[J]. American journal of respiratory and critical care medicine, 2005, 172(12): 1497-1504.
[17].De Backer W, Devolder A, Poli G, et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients[J]. Journal of aerosol medicine and pulmonary drug delivery, 2010, 23(3): 137-148.
[18].Laube B L, Janssens H M, de Jongh F H C, et al. What the pulmonary specialist should know about the new inhalation therapies[J]. 2011.
[19].Foster training manual-Modulite technology;page 17.
[20].Muller V, Galffy G, Eszes N, et al. Asthma control in patients receiving inhaled corticosteroid and long-acting beta. sub. 2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation[J]. BMC Pulmonary Medicine, 2011, 11: 40-40.
▲ 聲明：本文旨在傳遞醫藥前言信息 ， 不應被理解為對相關藥品或診療方案的推薦 ， 本文涉及信息僅供參考 。 具體疾病診療請遵從醫生或其他醫療衛生專業人士的意見或指導 。
本文作者丨BioTalker